|
||||||
| Home |
| Find a Clinical Trial |
| Clinical Trial FAQs |
| About Informed Consent |
| Clinical Trials Glossary |
| Medical Research Areas |
| Clinical Trial Resources |
|
 |
Sign up and receive information about Novartis clinical trials in your health-related areas of interest. For U.S. residents only. | |
|
|
 |
|
|
|
|||
|
Novartis Clinical
Trials provides information about research studies recruiting
within the U.S. Visit ClinicalTrials.gov, a registry of federally and privately supported clinical trial for more information regarding clinical trials outside of the U.S. |
|
|
Find a Clinical Trial
Cold Sores
Cold sores are caused by the herpes simplex virus--one of the same family of viruses that causes chicken pox and mononucleosis. Herpes simplex virus type 1 (HSV-1) usually causes cold sores or oral herpes on the face and mouth.
Novartis is seeking people to participate in a clinical trial(s) testing the safety and effectiveness of Novartis products. Novartis recommends that you consult your doctor before participating in a clinical trial. For more information about clinical trial participation, click here. Also, for additional information about how Novartis helps to protect the privacy of the personal information that you provide to us, please see the Novartis Privacy Policy. Please review the details of the clinical trial(s) listed below and click on the one that you feel best suits your (or the participant's) condition.
Adolescent Cold Sores Study CFAM810B2305
The purpose of this study is to collect safety information and to measure the effectiveness of a study drug for reducing recurring cold sores in adolescent patients.
This study drug is a medicine which is approved by the Food and Drug Administration (FDA) in the treatment of ONLY adults with cold sores.
Trial phase: Phase 3 Participation Duration: Participants will be required to visit the study center at least 2 times over the duration of approximately 5 weeks. Protocol Number: CFAM810B2305 |